Ahmed Magdy Rabea/LinkedIn
Jun 21, 2025, 20:02
Ahmed Magdy Rabea: Introducing ADC Academy – A New Learning Platform for Advancing Oncology Therapeutics
Ahmed Magdy Rabea, Assistant Professor of Medical Oncology and Hematology at the National Cancer Institute, shared a post on LinkedIn:
“Happy to unveil the introductory video for the ADC Academy, a new learning platform dedicated to Antibody-Drug Conjugates (ADCs) – developed through a unique collaboration between CAIRO Journal Club and AstraZeneca
This platform is designed to empower healthcare professionals with the latest knowledge and insights into ADC science, clinical applications, and evolving treatment paradigms.
What to expect:
- The vision behind ADC Academy
- Why ADCs are revolutionizing oncology
- What you can expect from the platform – expert-led content, case-based learning, and interactive modules
Whether you’re a physician, pharmacist, or researcher, ADC Academy is your gateway to staying ahead in the rapidly advancing world of targeted cancer therapeutics.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 17:07
Jun 23, 2025, 15:18